Advanced Sequencing Equipment Supplied In France

An accurate tissue-based test to predict non-evolutive localized prostate cancer (LPCa). ...

Tempus xE (version 2) is a whole exome next-generation sequencing assay that analyzes the entire coding region (exome) of the patient’s genome, combined with whole transcriptome RNA sequencing. Clinical sequencing is performed to 500x depth of coverage for tumor specimens and 150x for normal specimens for the clinically enhanced regions ...

FIMICS PANEL a long non-coding RNA panel to better characterize cardiac disorders and ...